In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
ENIGMA-TRS 2 is a global, randomized, double-blind, placebo-controlled 12-week Phase III clinical study designed to enroll at least 400 patients; topline results are expected by Q4 2026Evenamide is a ...
This transcript has been edited for clarity. John Kane, MD: Hi. I'm Dr John Kane, professor of psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York. Welcome ...
First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...
In its first Phase Three clinical test, an experimental antipsychotic medicine called lumateperone has shown evidence of being both effective and safe. That is the conclusion of a research team that ...
Scientists with UT Southwestern's Peter O'Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication. The findings ...
Second-Generation Antipsychotic Drugs This table lists the atypical antipsychotics. For a story on the lessons of the CATIE trial, click here. For a table of first-generation drugs, click here. For a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback